Abstract
The present invention relates to a field of genetically modified fungal cells and converting galacturonic acid to meso-galactaric acid, more precisely to a method of producing meso-galactaric acid. The invention further relates to recombinant fungal cells having a specific combination of modifications including but not limited to expression of uronate dehydrogenase enzyme, reduced D-galacturonic acid reductase activity, and furthermore reduced meso-galactaric acid catabolism, as well as uses and methods related thereto.
Patent family as of 13.12.2021
CN109477078 A 20190315 CN201780044567 20170519
EP3458578 A1 20190327 EP20170731937 20170519
US10982239 BB 20210420 US20180302836 20170519
US2019256875 AA 20190822 US20180302836 20170519
WO17198908 A1 20171123 WO2017FI50378 20170519
Link to currentpatent family on right
| Original language | English |
|---|---|
| Patent number | US2019256875 |
| IPC | C12R 1/ 885 A N |
| Priority date | 19/05/17 |
| Publication status | Published - 22 Aug 2019 |
| MoE publication type | H1 Granted patent |